Dental Biomaterials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Dental Biomaterials Market is projected to expand from USD 8.53 Billion in 2025 to USD 12.19 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 6.13%. These biomaterials consist of a variety of biocompatible synthetic and natural substances designed to repair damaged structures, replace missing teeth, or regenerate oral tissues. The market is primarily propelled by an aging global population requiring restorative care and an increasing prevalence of periodontal disorders. Furthermore, strong consumer preference for aesthetic dental improvements and cosmetic procedures establishes a solid foundation for continued industry growth, distinguishing these fundamental drivers from temporary technological trends.

However, the high cost of advanced dental treatments and insufficient reimbursement coverage in emerging economies pose significant challenges that could hinder broader market adoption. These financial constraints limit accessibility for a large segment of the patient population. Despite these economic pressures, the sector remains resilient; according to the American Dental Association, consumer dental spending in the United States rose by 4% as of August 2025 compared to the beginning of the year, underscoring the sustained demand for material-intensive dental services.

Market Drivers

The increasing penetration of dental implants and restorative solutions acts as a vital catalyst for the sector, substantially boosting the consumption of bone grafts, barrier membranes, and osseointegrative substances. As patients increasingly favor fixed prosthetic options over removable dentures, the need for advanced biocompatible materials that offer long-term stability has surged. This trend is evident in the operational scale of key industry players seeing higher patient numbers for replacement therapies. For instance, the Straumann Group reported in its 'Annual Report 2024' (February 2025) that the organization supported 6.7 million smiles in 2024, an increase of 1.1 million patients from the prior year. This rise in patient volume directly drives intensified demand for synthetic and xenogeneic substitutes used in ridge augmentation and socket preservation.

Concurrently, the rising incidence of dental caries and periodontal diseases ensures a steady volume of interventions, maintaining demand for restorative composites, cements, and regeneration agents. As healthcare infrastructure improves and patient access widens, the frequency of treatments fuels substantial material utilization. According to the NHS Business Services Authority's August 2025 report, 'NHS Dental Statistics - England 2024-25', 35 million courses of treatment were delivered during the 2024-25 financial year, a 4% increase from the previous period. This rebound in activity supports the financial performance of material manufacturers, as shown by Envista Holdings Corporation, which achieved third-quarter sales of $670 million in 2025 with 9.4% year-over-year core sales growth, illustrating strong capitalization on these persistent restorative care demands.

Market Challenges

The elevated cost associated with advanced dental treatments creates a severe economic barrier that limits the widespread adoption of premium dental biomaterials. When the acquisition price of synthetic bone grafts, membranes, and restorative composites rises, the operational overhead for dental practices increases disproportionately. If reimbursement rates from insurance providers or state healthcare systems do not adjust to match these rising input costs, dental professionals face financial disincentives to use top-tier biomaterials. This price sensitivity often forces practitioners to absorb the deficit or choose less expensive, lower-quality alternatives, effectively capping the sales volume of advanced materials and restricting market penetration to affluent patient demographics.

This financial strain is further exacerbated by inflationary pressures on the supply chain, which directly erode the profit margins necessary to sustain a material-intensive industry. As procurement costs climb, the gap between the expense of delivering care and available funding widens, leading to stagnated inventory turnover. According to the American Dental Association in 2025, the majority of surveyed dental practices reported that prices for equipment and supplies had increased by more than 5% since the start of the year. This measurable rise in material costs, without a commensurate increase in reimbursement, directly hampers the growth of the Global Dental Biomaterials Market by reducing the purchasing power of primary end-users.

Market Trends

The expansion of digital and 3D-printable material portfolios is fundamentally transforming clinical workflows by enabling the direct fabrication of complex appliances with high precision. This trend is defined by the increasing adoption of specialized biocompatible resins and thermoplastics that operate seamlessly within CAD/CAM ecosystems, effectively replacing traditional analog impression materials. As dental professionals prioritize efficiency, the consumption of these digitally optimized materials for clear aligners and printed prosthetics has accelerated, driving manufacturers to broaden their formulations. According to Align Technology's 'Q3 2025 Financial Results' from October 2025, clear aligner volume increased by 4.9% year-over-year to 647.8 thousand cases, demonstrating the sustained industrial scale of digital material utilization in orthodontic treatments.

Simultaneously, there is a surge in demand for high-translucency zirconia and all-ceramic solutions, driven by patient requirements for superior aesthetics and metal-free restorations. This market shift is accelerating the decline of porcelain-fused-to-metal frameworks in favor of monolithic materials that combine high fracture toughness with natural optical properties. The integration of intraoral scanners further catalyzes this transition, as digital impressions seamlessly interface with milling units to produce these ceramic restorations rapidly. According to the Modern Dental Group's 'Interim Report 2025' (August 2025), the volume of digital solution cases produced at its major facilities increased by 24.4% year-over-year to approximately 457,653 units, reflecting the dominant market preference for millable ceramic systems.

Key Players Profiled in the Dental Biomaterials Market

• Institut Straumann AG
• Geistlich Pharma AG
• Zimmer Biomet Holdings, Inc.
• Danaher Corporation
• Dentsply Sirona, Inc.
• 3M Company
• CRS Holdings, LLC.
• Medtronic PLC
• Henry Schein, Inc.
• Mitsui Chemicals, Inc.

Report Scope

In this report, the Global Dental Biomaterials Market has been segmented into the following categories:

Dental Biomaterials Market, by Type:

• Metallic Biomaterials
• Ceramic Biomaterials
• Polymeric Biomaterials
• Metal-Ceramic Biomaterials
• Natural Biomaterials
• Composites Biomaterials

Dental Biomaterials Market, by Application:

• Orthodontics
• Implantology
• Prosthodontics
• Others

Dental Biomaterials Market, by End User:

• Dental Hospitals& Clinics
• Dental laboratories
• Dental Academies and Research Institutes
• Dental Product manufacturers

Dental Biomaterials Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dental Biomaterials Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.